SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

73,709.69 -143.21
( -0.19%)

Global Indices

Nasdaq

52,511.77 524.74
(1.01%)

Dow Jones

7,731.20 19.47
(0.25%)

Hang Seng

64,728.80 653.38
(1.02%)

Nikkei 225

10,731.75 -32.94
(-0.31%)

Forex

USD-INR

94.90 0.12
(0.13%)

EUR-INR

106.44 -0.03
(-0.02%)

GBP-INR

126.38 0.12
(0.10%)

JPY-INR

0.60 0.00
(-0.04%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Natco Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524816

INE987B01026

501.202063

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

NATCOPHARM

17.61

15708.15

EPS(TTM)

Face Value()

Div & Yield %

45.47

0.57

Back

j l morison (india) ltd

ICICI Bank consolidated net profit rises 22.28% in the September 2026 quarter

Oct 17,2026

Net profit of ICICI Bank rose 22.28% to Rs 16333.18 crore in the quarter ended September 2026 as against Rs 13357.06 crore during the previous quarter ended September 2025. Total Operating Income rose 16.21% to Rs 55991.91 crore in the quarter ended September 2026 as against Rs 48180.91 crore during the previous quarter ended September 2025.

Particulars	Quarter Ended
	Sep. 2026	Sep. 2025	% Var.
Total Operating Income	55991.91	48180.91	16
OPM %	29.65	27.22	-
PBDT	23114.76	19064.58	21
PBT	23114.76	19064.58	21
NP	16333.18	13357.06	22

73,709.69 -143.21 ( -0.19%)

52,511.77 524.74 (1.01%)

7,731.20 19.47 (0.25%)

64,728.80 653.38 (1.02%)

10,731.75 -32.94 (-0.31%)

94.90 0.12 (0.13%)

106.44 -0.03 (-0.02%)

126.38 0.12 (0.10%)

0.60 0.00 (-0.04%)